STRATEC Biomedical AG
Open
17.92
Overzicht
Wijziging aandelenprijs
24u
Min
17.38
Max
18.18
Inkomsten | 2.6M -1.7M |
|---|---|
Verkoop | -22M 53M |
K/W Sectorgemiddelde | 14.63 30.487 |
EPS | -0.357 |
Dividendrendement | 3.57 |
Winstmarge | -3.206 |
Werknemers | 1,343 |
EBITDA | -6.7M 4.1M |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +57.3% upside |
Dividendrendement Sectorgemiddelde | 3.57% 3.24% |
|---|---|
Volgende Winsten | 14 aug 2026 |
Marktkapitalisatie | -1.9M 212M |
|---|---|
Vorige openingsprijs | 17.92 |
Vorige sluitingsprijs | 17.92 |
STRATEC Biomedical AG Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
